Search
Flurantel
go.drugbank.com/drugs/DB19840ExperimentalFlurantel is a small molecule drug. The usage of the INN stem '-antel' in the name indicates that Flurantel is a anthelminthic. Flurantel has a monoisotopic molecular weight of 494.05 Da.
Viquidil
go.drugbank.com/drugs/DB19920ExperimentalViquidil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Viquidil is a vasodilator. Viquidil has a monoisotopic molecular weight of 324.18 Da.
Mepramidil
go.drugbank.com/drugs/DB20025ExperimentalMepramidil is a small molecule drug. The usage of the INN stem '-dil' in the name indicates that Mepramidil is a vasodilator. Mepramidil has a monoisotopic molecular weight of 463.24 Da.
Mapinastine
go.drugbank.com/drugs/DB20076ExperimentalMapinastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Mapinastine is a antihistaminic. Mapinastine has a monoisotopic molecular weight of 410.28 Da.
Palinavir
go.drugbank.com/drugs/DB20083ExperimentalPalinavir is a small molecule drug. The usage of the INN stem '-vir' in the name indicates that Palinavir is a antiviral. Palinavir has a monoisotopic molecular weight of 708.4 Da.
Zanoterone
go.drugbank.com/drugs/DB21384ExperimentalZanoterone is a small molecule drug. The usage of the INN stem '-terone' in the name indicates that Zanoterone is a antiandrogen. Zanoterone has a monoisotopic molecular weight of 416.21 Da.
Bamirastine
go.drugbank.com/drugs/DB21186ExperimentalBamirastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Bamirastine is a antihistaminic. Bamirastine has a monoisotopic molecular weight of 527.29 Da.
Barmastine
go.drugbank.com/drugs/DB21253ExperimentalBarmastine is a small molecule drug. The usage of the INN stem '-astine' in the name indicates that Barmastine is a antihistaminic. Barmastine has a monoisotopic molecular weight of 483.24 Da.
Acetrizoic acid
go.drugbank.com/drugs/DB09347ApprovedWithdrawn[L1704] Acetrizoic acid presents, in the FDA records, a category of drug substance with an inactive status.[L1703] … [A32135] It was first synthesized by Wallingford in 1953[A32136] and it was filled in the FDA by the Johnson & Johnson subsidiary, Cilag Chemie AG, on February 8th, 1978.
Categories: Compounds used in a research, industrial, or household settingTapentadol
go.drugbank.com/drugs/DB06204ApprovedInvestigationalTapentadol is a centrally-acting synthetic analgesic with a dual mechanism of action. It is a mu-opioid receptor agonist that also inhibits norepinephrine reuptake. … [A260721, A36596] Tapentadol was first approved by the FDA on November 20, 2008. The extended-release formulation of tapentadol was also approved by the FDA on August 26, 2011.